Guidelines for Offering Preventive Mastectomy to High-Risk Women
New research indicates that extending preventive mastectomy to women with a higher lifetime risk of breast cancer can significantly reduce disease incidence, supported by cost-effectiveness analyses.
Recent research conducted by experts from Queen Mary University of London, the London School of Hygiene and Tropical Medicine, Manchester University, and Peking University suggests that more women at an elevated risk of developing breast cancer should consider preventive mastectomy. Traditionally, this surgical intervention is reserved for women carrying high-penetrance genetic mutations like BRCA1, BRCA2, and PALB2. However, the new analysis indicates that expanding criteria based on individual risk assessments could significantly reduce breast cancer incidence.
The study, published in JAMA Oncology, utilized a sophisticated economic evaluation model aligned with NHS guidelines to determine when mastectomy becomes a cost-effective strategy. The findings reveal that women over age 30 with a lifetime breast cancer risk of 35% or higher could substantially benefit from RRM, potentially preventing approximately 6,500 cases annually in the UK.
Personalized risk prediction models, factoring in genetic and other health data, currently guide treatment decisions such as mammograms, MRI screenings, medication, or surgery. But this research advocates for a broader application of risk-reducing surgery beyond women with known genetic mutations. The key is identifying individuals with a sufficiently high predicted risk where surgery offers not only health benefits but also economic value.
Using a cost-effectiveness threshold of £30,000 per quality-adjusted life year (QALY), the study highlights that mastectomy becomes a prioritized prevention method for women aged 30 to 55 with a lifetime risk of 35% or more. Implementing such measures could lead to a meaningful reduction in breast cancer cases and improve health outcomes.
Professor Ranjit Manchanda emphasized that this work defines specific risk levels at which mastectomy should be recommended and calls for further research on patient acceptability and long-term outcomes. Dr. Rosa Legood added that, for women within this risk group, RRM is a viable, economic preventive option. Funding from organizations like Rosetrees Trust supports this groundbreaking effort to personalize breast cancer prevention strategies.
Overall, the study suggests that expanding surgical prevention frameworks based on individual risk could have a significant impact on breast cancer prevention, saving lives and optimizing healthcare resources.
Source: https://medicalxpress.com/news/2025-07-mastectomy-women-higher-breast-cancer.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Discovery of a Key Chemical that Enhances Esophageal and Upper Stomach Muscle Movement
A groundbreaking study reveals how the bodily chemical PAF stimulates muscle contractions in the esophagus and upper stomach, offering new insights into digestive and allergic conditions.
UK Study Assesses the Success of Non-Specific Symptom-Based Cancer Diagnosis Pathway
A major UK study evaluates the effectiveness of the SCAN Pathway for diagnosing cancers and other serious conditions in patients with non-specific symptoms, highlighting key outcomes and resource considerations.
HIV-1's Hidden Strategy: Circular RNAs Enable Virus to Evade the Immune System
Researchers have discovered that HIV-1 produces circular RNAs to evade immune defenses, enabling the virus to persist and replicate more effectively. This breakthrough offers new targets for therapy and improves understanding of HIV's resilience.
The Impact of the Republican Megabill on Americans' Healthcare Costs
A new Republican proposal aims to cut healthcare funding by $1 trillion, potentially increasing the number of uninsured Americans and straining healthcare providers, especially in rural areas.